A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting
Clinical trial NCT04089839 · COMPLETED
Trial details
- NCT number
- NCT04089839
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-21
- Primary completion
- 2020-01-16
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.